Le Lézard
Classified in: Health, Business
Subject: TNM

Symbility Solutions is Acquired by CoreLogic


TORONTO, Dec. 18, 2018 /CNW/ - Symbility Solutions Inc. ("Symbility") (TSXV: SY) announced that CoreLogic, Inc. ("CoreLogic") (NYSE: CLGX), through its indirect wholly owned subsidiary, 2154638 Alberta Ltd., has completed the acquisition of all of the issued and outstanding common shares of Symbility not already owned by it or its affiliates for a purchase price of $0.615 per common share. The acquisition took place by way of a plan of arrangement under Section 193 of the Business Corporations Act (Alberta) (the "Arrangement"), which was approved by the Court of Queen's Bench of Alberta on December 17, 2018.  As a result of the Arrangement, Symbility is now an indirect wholly-owned subsidiary of CoreLogic.

Symbility Solutions (CNW Group/Symbility Solutions Inc.)

Trading of Symbility's common shares is expected to be halted until they are delisted from the TSX Venture Exchange on or about December 20, 2018. Symbility will also submit an application to cease to be a reporting issuer under the securities laws of the applicable provinces of Canada.

ABOUT SYMBILITY

Symbility believes in creating world-class experiences that simplify business and improve lives. With a history in modernizing insurance claims solutions for the property and health industries, Symbility has established itself as a partner that puts security, efficiency and customer experience first. Symbility PROPERTYtm brings smarter thinking to property insurance. Our strategic services team, Symbility INTERSECTtm empowers a variety of businesses with smarter mobile and IoT product development strategy, design thinking and engineering excellence. We push industries forward and prove that change for the better is entirely possible. For more information, please visit www.symbilitysolutions.com.

LEGAL NOTICE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements" about the Arrangement within the meaning of applicable Canadian securities legislation. These forwarding-looking statements in this news release are related to, but are not limited to, matters with respect to the timing and completion of the post-closing matters related to the Arrangement. Forward-looking statements typically contain statements with words such as "expect," "anticipate," "believe", "foresee", "could", "estimate", "goal", "intend", "plan", "seek", "strive", "will", "may" and "should" and similar expressions.

Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Symbility's expectations only as of the date of this news release. Symbility disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

All trade names are the property of their respective owners.

SOURCE Symbility Solutions Inc.


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: